These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16634107)

  • 1. Design and synthesis of simple macrocycles active against vancomycin-resistant enterococci (VRE).
    Jia Y; Ma N; Liu Z; Bois-Choussy M; Gonzalez-Zamora E; Malabarba A; Brunati C; Zhu J
    Chemistry; 2006 Jul; 12(20):5334-51. PubMed ID: 16634107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
    Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of macrocycles active against vancomycin-resistant enterococci (VRE): the interplay between d-Ala-d-Lac binding and hydrophobic effect.
    Ma N; Jia Y; Liu Z; Gonzalez-Zamora E; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    Bioorg Med Chem Lett; 2005 Feb; 15(3):743-6. PubMed ID: 15664849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of synthetic compounds active against VRE: the role of the lipidated aminoglucose and the structure of glycopeptide binding pocket.
    Jia Y; Gonzalez-Zamora E; Ma N; Liu Z; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4594-9. PubMed ID: 16099650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds.
    Yamamoto Y; Kurazono M
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1626-8. PubMed ID: 17254785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 16-membered cyclopeptides active against vancomycin-resistant Enterococci (VRE).
    Zhu J
    Chimia (Aarau); 2013; 67(12-13):916-20. PubMed ID: 24594338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci.
    Xing B; Yu CW; Ho PL; Chow KH; Cheung T; Gu H; Cai Z; Xu B
    J Med Chem; 2003 Nov; 46(23):4904-9. PubMed ID: 14584941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 2.
    Bremner JB; Keller PA; Pyne SG; Boyle TP; Brkic Z; Morgan J; Somphol K; Coates JA; Deadman J; Rhodes DI
    Bioorg Med Chem; 2010 Jul; 18(13):4793-800. PubMed ID: 20627739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and their combinations with vancomycin.
    Sato M; Tanaka H; Oh-Uchi T; Fukai T; Etoh H; Yamaguchi R
    Phytother Res; 2004 Nov; 18(11):906-10. PubMed ID: 15597305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1.
    Bremner JB; Keller PA; Pyne SG; Boyle TP; Brkic Z; David DM; Robertson M; Somphol K; Baylis D; Coates JA; Deadman J; Jeevarajah D; Rhodes DI
    Bioorg Med Chem; 2010 Apr; 18(7):2611-20. PubMed ID: 20236828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus.
    Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5870-3. PubMed ID: 16942872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
    Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
    J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE.
    Shimamura H; Gouda H; Nagai K; Hirose T; Ichioka M; Furuya Y; Kobayashi Y; Hirono S; Sunazuka T; Omura S
    Angew Chem Int Ed Engl; 2009; 48(5):914-7. PubMed ID: 19115340
    [No Abstract]   [Full Text] [Related]  

  • 16. The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci.
    Arnusch CJ; Bonvin AM; Verel AM; Jansen WT; Liskamp RM; de Kruijff B; Pieters RJ; Breukink E
    Biochemistry; 2008 Dec; 47(48):12661-3. PubMed ID: 18989934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Garrison MW; Nuemiller JJ
    Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4'''-N-demethylspiramycin derivatives: synthesis and evaluation of effectiveness against drug-resistant bacteria.
    Sunazuka T; Shudo H; Nagai K; Yoshida K; Yamaguchi Y; Hanaki H; Omura S
    J Antibiot (Tokyo); 2008 Mar; 61(3):175-84. PubMed ID: 18503196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin.
    Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS
    J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.